title: Sensitive enzyme immunoassay for measuring plasma and intracellular nevirapine levels in human immunodeficiency virus-infected patients.
abstract: We have developed an enzyme immunoassay to measure nevirapine (NVP) in plasma and peripheral blood mononuclear cells. Anti-NVP polyclonal antibodies were raised in rabbits by using a synthetic NVP derivative coupled to keyhole limpet hemocyanin as the immunogen, and the enzyme tracer was prepared by chemically coupling the NVP derivative with acetylcholinesterase. These reagents were used to develop a sensitive competitive enzyme immunoassay performed in microtitration plates with a 100-pg ml(-1) limit of detection and thus approximately 100 times more sensitive than previously published techniques. The plasma assay was performed directly without extraction (in this case, a 500-pg ml(-1) limit of detection was observed) on a minimum of 30 micro l of plasma. This assay shows good precision and efficiency, since recovery from human plasma and cell extracts spiked with NVP ranged between 87 and 104%, with coefficients of variation of <10%. A pharmacokinetic analysis of plasma NVP was performed for seven patients infected with human immunodeficiency virus (HIV), and it gave results similar to published findings. Intracellular concentrations of NVP were measured in cultured human T-lymphoblastoid cells and peripheral blood mononuclear cells from HIV-infected patients. The results indicated a very low intracellular/extracellular concentration ratio (0.134), thus demonstrating the absence of intracellular drug accumulation. This is the first intracellular assay of a nonnucleoside reverse-transcriptase inhibitor, and this method could be useful in monitoring plasma and intracellular NVP levels in HIV-infected patients.
authors.affiliation: Laboratoire de Chimie Bio-Organique, Université de Nice-Sophia Antipolis, Hôpital Archet, Nice, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Azoulay
authors.forename: Marie-Claire
authors.initials: MC
authors.lastname: Nevers
authors.forename: Christophe
authors.initials: C
authors.lastname: Créminon
authors.forename: Laurence
authors.initials: L
authors.lastname: Heripret
authors.forename: Jacques
authors.initials: J
authors.lastname: Durant
authors.forename: Pierre
authors.initials: P
authors.lastname: Dellamonica
authors.forename: Jacques
authors.initials: J
authors.lastname: Grassi
authors.forename: Roger
authors.initials: R
authors.lastname: Guedj
authors.forename: Danièle
authors.initials: D
authors.lastname: Duval
mesh_terms: D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000032:analysis* / Q000097:blood; D002478:Cells, Cultured; D005260:Female; D015658:HIV Infections / Q000097:blood*; D006801:Humans; D007124:Immunoenzyme Techniques; D007202:Indicators and Reagents; D007962:Leukocytes / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000032:analysis* / Q000097:blood; D011817:Rabbits / Q000276:immunology; D015203:Reproducibility of Results; D013601:T-Lymphocytes / Q000737:chemistry / Q000378:metabolism; D013696:Temperature
chemical_list: D019380:Anti-HIV Agents; D007202:Indicators and Reagents; D019829:Nevirapine